Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Neurology

• Publication date

  2018-07-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1111/ene.13637PMID 29573167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parkinson's disease and transcranial pulsed electromagnetic fields: A randomized clinical trial

  2017influential reference
• Neuropathological basis of nonmotor manifestations of Parkinson's disease

  2016cited by this paper
• New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.

  2015cited by this paper
• Effects of electromagnetic field (PEMF) exposure at different frequency and duration on the peripheral nerve regeneration: in vitro and in vivo study

  2015cited by this paper
• The pathomechanisms underlying Parkinson's disease

  2014cited by this paper
• ASSA14-03-01 Pulsed Electromagnetic Field Improves Postnatal Neovascularization in Response to Hindlimb Ischemia

  2014cited by this paper
• Pulsed electromagnetic field enhances brain-derived neurotrophic factor expression through L-type voltage-gated calcium channel- and Erk-dependent signaling pathways in neonatal rat dorsal root ganglion neurons.

  2014cited by this paper
• Pulsed electromagnetic fields potentiate neurite outgrowth in the dopaminergic MN9D cell line

  2014cited by this paper
• Effect of Pulsed Electromagnetic Field (PEMF) on Infarct Size and Inflammation After Cerebral Ischemia in Mice

  2014cited by this paper
• Dose-remission of pulsating electromagnetic fields as augmentation in therapy-resistant depression: a randomized, double-blind controlled study

  2014cited by this paper
• α-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology

  2013cited by this paper
• Therapeutic effects of whole‐body devices applying pulsed electromagnetic fields (PEMF): A systematic literature review

  2012cited by this paper
• Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury.

  2012cited by this paper
• Clinical subtypes of Parkinson's disease

  2011cited by this paper
• Determinants of health-related quality of life in Parkinson's disease: a systematic review.

  2011cited by this paper
• Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression.

  2010cited by this paper
• Self‐management rehabilitation and health‐related quality of life in Parkinson's disease: A randomized controlled trial

  2010cited by this paper
• Headache Treatment with Pulsing Electromagnetic Fields: A Literature Review

  2007cited by this paper
• Expanding Use of Pulsed Electromagnetic Field Therapies

  2007cited by this paper
• Impact of the motor complications of Parkinson's disease on the quality of life

  2005cited by this paper
• Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF‐2

  2004cited by this paper
• Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire.

  2001cited by this paper
• Directed and enhanced neurite growth with pulsed magnetic field stimulation.

  2000cited by this paper
• PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures

  1998cited by this paper
• The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

  1997cited by this paper
• The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease

  1995cited by this paper
• [Clinical subtypes of Parkinson's disease].

  1993cited by this paper

• Magnetic Field-Guided Magnetic Nanoparticles as Neurotherapeutics for Neurological Disorders and Glioblastoma.

  2026cites this paper
• Emerging Noninvasive Approaches for the Suppression of Pathological Tremor

  2025cites this paper
• Metabolomics comparison of metabolites and functional pathways in the SH-SY5Y cell model of Parkinson's disease under PEMF exposure

  2024cites this paper
• Pulsating Extremely Low-Frequency Electromagnetic Fields Influence Differentiation of Mouse Neural Stem Cells towards Astrocyte-like Phenotypes: In Vitro Pilot Study

  2024cites this paper
• Neuron Foundry Mach 8: A Concept of Multi-modal Neuro-supportive Energy Therapy Device for Treating Neurodegenerative Disorders

  2024cites this paper
• Efectos secundarios de las Terapias Complementarias. Un estudio observacional.

  2023cites this paper
• Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson’s disease

  2021cites this paper
• The role of magnetic fields in neurodegenerative diseases

  2020cites this paper
• The influence of posture duration on hand tremor during tasks with attention-distraction in persons with Parkinson’s disease

  2019cites this paper
• University of Southern Denmark The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson's disease Malling,

  2019influential citation
• The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson’s disease

  2019cites this paper
• Syddansk Universitet The effect of 8 weeks of treatment with transcranial pulsed electromagnetic fields on hand tremor and inter-hand coherence in persons with Parkinson ' s disease Malling

  2019cites this paper
• Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson’s disease: A randomized clinical trial

  2018cites this paper
• The Hawthorne effect as a pre-placebo expectation in Parkinsons disease patients participating in a randomized placebo-controlled clinical study

  2018cites this paper